Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

09 août 2018 07h37 HE | Source: Precipio, Inc.

Precipio Appoints New Board Member to Replace Departing Director

Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
18 juil. 2018 07h37 HE | Source: Precipio, Inc.

Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results

Third consecutive quarter of triple-digit YoY Quarterly growth NEW HAVEN, Conn., July 18, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today...
26 juin 2018 08h00 HE | Source: Precipio, Inc.

Precipio and Nucleai Partner to Develop Artificial Intelligence-Powered Hemepath Solution

System will support Hematopathologists in accurately identifying abnormalities to ensure diagnostic accuracy NEW HAVEN, Conn., June 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
19 juin 2018 07h38 HE | Source: Precipio, Inc.

Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology

Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
15 juin 2018 20h11 HE | Source: Precipio, Inc.

Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders

NEW HAVEN, Conn., June 15, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that the Company’s 2018 Annual Meeting of Shareholders, originally...
14 juin 2018 12h19 HE | Source: Precipio, Inc.

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

NEW HAVEN, Conn., June 14, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
12 juin 2018 08h00 HE | Source: Precipio, Inc.

Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018

NEW HAVEN, Conn., June 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the...
06 juin 2018 07h38 HE | Source: Precipio, Inc.

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...
24 mai 2018 07h38 HE | Source: Precipio, Inc.

Precipio Launches Liquid Biopsy DNA Enrichment Sales in Europe with First Order

$10 million annual Europe market anticipated with $1 million annual addressable sales potential from local Italy partner NEW HAVEN, Conn., May 24, 2018 (GLOBE NEWSWIRE) -- Specialty cancer...
22 mai 2018 07h37 HE | Source: Precipio, Inc.

Potential Sequential Revenue Run-Rate Growth of 30% over Q1, based on Preliminary April Results

NEW HAVEN, Conn., May 22, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced accelerating sales of its Pathology services in the month of...

Page précédente